Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Expanding innovative portfolio may drive gains for Sun Pharma stock

Lerodalcibep licensing deal, growth in the US portfolio and tariff relief offer triggers, while the proposed Organon acquisition could broaden its global reach

Expanding innovative portfolio may drive gains for Sun Pharma stock

We haven't written up this one. Business Standard IN has the full story — the link below goes straight to it.

Read the original at business-standard.com →

More in Finance & Markets

More from Tuesday 29 September →